ELV logo

Elevance Health, Inc. (ELV) Cash From Investing

Annual CFI:

-$5.17B+$405.00M(+7.27%)
December 31, 2024

Summary

  • As of today, ELV annual cash from investing is -$5.17 billion, with the most recent change of +$405.00 million (+7.27%) on December 31, 2024.
  • During the last 3 years, ELV annual cash from investing has risen by +$4.47 billion (+46.39%).
  • ELV annual cash from investing is now -272.07% below its all-time high of $3.00 billion, reached on December 31, 2009.

Performance

ELV Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Quarterly CFI:

-$1.22B-$537.00M(-78.17%)
September 30, 2025

Summary

  • As of today, ELV quarterly cash from investing is -$1.22 billion, with the most recent change of -$537.00 million (-78.17%) on September 30, 2025.
  • Over the past year, ELV quarterly cash from investing has dropped by -$823.00 million (-205.24%).
  • ELV quarterly cash from investing is now -129.40% below its all-time high of $4.16 billion, reached on December 31, 2009.

Performance

ELV Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

TTM CFI:

-$3.45B-$823.00M(-31.38%)
September 30, 2025

Summary

  • As of today, ELV TTM cash from investing is -$3.45 billion, with the most recent change of -$823.00 million (-31.38%) on September 30, 2025.
  • Over the past year, ELV TTM cash from investing has increased by +$1.11 billion (+24.40%).
  • ELV TTM cash from investing is now -186.46% below its all-time high of $3.99 billion, reached on March 31, 2010.

Performance

ELV TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ELV Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.3%-205.2%+24.4%
3Y3 Years+46.4%+1.8%+40.7%
5Y5 Years-85.1%-1475.3%+50.1%

ELV Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-13.3%+46.4%-523.5%+61.6%-31.4%+44.1%
5Y5-Year-85.1%+46.4%-501.3%+75.2%-31.4%+64.3%
All-TimeAll-Time-272.1%+46.4%-129.4%+75.2%-186.5%+64.3%

ELV Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$1.22B(-78.2%)
-$3.45B(-31.4%)
Jun 2025
-
-$687.00M(-767.0%)
-$2.62B(+4.8%)
Mar 2025
-
$103.00M(+106.3%)
-$2.75B(+46.7%)
Dec 2024
-$5.17B(+7.3%)
-$1.64B(-308.5%)
-$5.17B(-13.4%)
Sep 2024
-
-$401.00M(+51.0%)
-$4.56B(+5.9%)
Jun 2024
-
-$818.00M(+64.6%)
-$4.84B(-3.1%)
Mar 2024
-
-$2.31B(-124.5%)
-$4.70B(+15.7%)
Dec 2023
-$5.57B(-22.2%)
-$1.03B(-49.8%)
-$5.57B(-31.0%)
Sep 2023
-
-$687.00M(-2.2%)
-$4.25B(+11.6%)
Jun 2023
-
-$672.00M(+78.9%)
-$4.81B(+21.9%)
Mar 2023
-
-$3.18B(-1201.7%)
-$6.17B(-35.2%)
Dec 2022
-$4.56B(+52.7%)
$289.00M(+123.2%)
-$4.56B(+21.6%)
Sep 2022
-
-$1.25B(+38.4%)
-$5.82B(+3.2%)
Jun 2022
-
-$2.02B(-28.3%)
-$6.01B(+32.6%)
Mar 2022
-
-$1.58B(-63.4%)
-$8.91B(+7.6%)
Dec 2021
-$9.64B(-31.6%)
-$966.00M(+32.9%)
-$9.64B(-15.2%)
Sep 2021
-
-$1.44B(+70.8%)
-$8.37B(-22.4%)
Jun 2021
-
-$4.92B(-113.5%)
-$6.84B(+0.1%)
Mar 2021
-
-$2.31B(-856.4%)
-$6.85B(+6.5%)
Dec 2020
-$7.32B(-162.3%)
$305.00M(+242.7%)
-$7.32B(-6.1%)
Sep 2020
-
$89.00M(+101.8%)
-$6.91B(+20.6%)
Jun 2020
-
-$4.93B(-77.2%)
-$8.69B(-76.5%)
Mar 2020
-
-$2.78B(-485.1%)
-$4.92B(-76.4%)
Dec 2019
-$2.79B(-121.8%)
$723.00M(+142.6%)
-$2.79B(-1.8%)
Sep 2019
-
-$1.70B(-45.8%)
-$2.74B(-58.3%)
Jun 2019
-
-$1.17B(-78.7%)
-$1.73B(-28.7%)
Mar 2019
-
-$652.00M(-184.3%)
-$1.35B(-6.8%)
Dec 2018
-$1.26B(+75.2%)
$773.00M(+212.4%)
-$1.26B(+77.7%)
Sep 2018
-
-$687.80M(+11.6%)
-$5.65B(-36.0%)
Jun 2018
-
-$778.30M(-37.5%)
-$4.16B(+6.0%)
Mar 2018
-
-$565.90M(+84.4%)
-$4.42B(+13.0%)
Dec 2017
-$5.08B(-889.0%)
-$3.62B(-548.6%)
-$5.08B(-542.7%)
Sep 2017
-
$807.10M(+177.5%)
-$790.80M(+26.4%)
Jun 2017
-
-$1.04B(+15.1%)
-$1.07B(-207.2%)
Mar 2017
-
-$1.23B(-282.9%)
-$349.90M(+31.9%)
Dec 2016
-$513.90M(+55.4%)
$670.90M(+28.3%)
-$513.90M(+7.3%)
Sep 2016
-
$523.00M(+265.1%)
-$554.10M(+33.4%)
Jun 2016
-
-$316.80M(+77.2%)
-$832.60M(-592.4%)
Mar 2016
-
-$1.39B(-320.5%)
$169.10M(+114.7%)
Dec 2015
-$1.15B(-18.1%)
$630.70M(+158.0%)
-$1.15B(-2.6%)
Sep 2015
-
$244.50M(-64.3%)
-$1.12B(+23.9%)
Jun 2015
-
$684.90M(+125.3%)
-$1.47B(+49.9%)
Mar 2015
-
-$2.71B(-510.8%)
-$2.94B(-201.8%)
Dec 2014
-$974.90M(+56.4%)
$660.10M(+712.9%)
-$974.90M(+45.3%)
Sep 2014
-
-$107.70M(+86.2%)
-$1.78B(-5.0%)
Jun 2014
-
-$783.00M(-5.2%)
-$1.70B(+4.8%)
Mar 2014
-
-$744.30M(-404.3%)
-$1.78B(+20.2%)
Dec 2013
-$2.23B(+50.9%)
-$147.60M(-530.8%)
-$2.23B(+33.4%)
Sep 2013
-
-$23.40M(+97.3%)
-$3.35B(+27.9%)
Jun 2013
-
-$867.80M(+27.4%)
-$4.65B(+19.4%)
Mar 2013
-
-$1.20B(+5.6%)
-$5.77B(-26.7%)
DateAnnualQuarterlyTTM
Dec 2012
-$4.55B(-383.2%)
-$1.27B(+3.9%)
-$4.55B(-56.7%)
Sep 2012
-
-$1.32B(+33.7%)
-$2.90B(-19.1%)
Jun 2012
-
-$1.99B(>-9900.0%)
-$2.44B(-102.6%)
Mar 2012
-
$20.10M(-94.7%)
-$1.20B(-27.8%)
Dec 2011
-$942.00M(+25.9%)
$381.20M(+144.7%)
-$942.00M(+33.9%)
Sep 2011
-
-$853.00M(-13.4%)
-$1.43B(-0.3%)
Jun 2011
-
-$752.30M(-366.7%)
-$1.42B(-20.4%)
Mar 2011
-
$282.10M(+375.0%)
-$1.18B(+7.1%)
Dec 2010
-$1.27B(-142.3%)
-$102.60M(+87.9%)
-$1.27B(-142.5%)
Sep 2010
-
-$849.00M(-65.9%)
$2.99B(-17.8%)
Jun 2010
-
-$511.80M(-366.7%)
$3.64B(-8.6%)
Mar 2010
-
$191.90M(-95.4%)
$3.99B(+32.7%)
Dec 2009
$3.00B(+387.3%)
$4.16B(+2165.1%)
$3.00B(+398.0%)
Sep 2009
-
-$201.60M(-20.0%)
-$1.01B(-26.0%)
Jun 2009
-
-$168.00M(+78.8%)
-$799.70M(-26.5%)
Mar 2009
-
-$790.90M(-617.9%)
-$632.30M(-202.6%)
Dec 2008
$616.20M(+180.1%)
$152.70M(+2249.2%)
$616.20M(-21.3%)
Sep 2008
-
$6.50M(+1183.3%)
$783.20M(+28.2%)
Jun 2008
-
-$600.00K(-100.1%)
$610.70M(+74.0%)
Mar 2008
-
$457.60M(+43.1%)
$350.90M(+145.6%)
Dec 2007
-$768.90M(-68.1%)
$319.70M(+292.6%)
-$768.90M(+44.5%)
Sep 2007
-
-$166.00M(+36.3%)
-$1.38B(+18.9%)
Jun 2007
-
-$260.40M(+60.7%)
-$1.71B(-236.7%)
Mar 2007
-
-$662.20M(-124.0%)
-$506.80M(-10.8%)
Dec 2006
-$457.30M(+89.7%)
-$295.60M(+39.4%)
-$457.30M(+84.6%)
Sep 2006
-
-$488.00M(-152.0%)
-$2.98B(+3.2%)
Jun 2006
-
$939.00M(+253.3%)
-$3.07B(+26.5%)
Mar 2006
-
-$612.70M(+78.2%)
-$4.18B(+5.4%)
Dec 2005
-$4.42B(-86.2%)
-$2.81B(-381.0%)
-$4.42B(-24.1%)
Sep 2005
-
-$585.20M(-244.6%)
-$3.56B(+3.8%)
Jun 2005
-
-$169.80M(+80.0%)
-$3.70B(-19.2%)
Mar 2005
-
-$850.60M(+56.5%)
-$3.11B(-30.9%)
Dec 2004
-$2.37B(-113.2%)
-$1.96B(-169.0%)
-$2.37B(-140.6%)
Sep 2004
-
-$727.30M(-270.7%)
-$986.60M(-270.1%)
Jun 2004
-
$426.00M(+467.6%)
-$266.60M(+67.8%)
Mar 2004
-
-$115.90M(+79.6%)
-$827.90M(+25.7%)
Dec 2003
-$1.11B(+21.1%)
-$569.40M(-7700.0%)
-$1.11B(-11.9%)
Sep 2003
-
-$7.30M(+94.6%)
-$995.30M(+50.3%)
Jun 2003
-
-$135.30M(+66.3%)
-$2.00B(-19.2%)
Mar 2003
-
-$401.60M(+11.0%)
-$1.68B(-19.0%)
Dec 2002
-$1.41B(-183.5%)
-$451.10M(+55.5%)
-$1.41B(-27.4%)
Sep 2002
-
-$1.01B(-643.1%)
-$1.11B(-405.2%)
Jun 2002
-
$186.70M(+239.9%)
-$219.40M(+58.8%)
Mar 2002
-
-$133.50M(+9.6%)
-$532.40M(-6.9%)
Dec 2001
-$498.10M(+34.6%)
-$147.60M(-18.1%)
-$498.10M(-42.1%)
Sep 2001
-
-$125.00M(+1.0%)
-$350.50M(-55.4%)
Jun 2001
-
-$126.30M(-27.3%)
-$225.50M(-127.3%)
Mar 2001
-
-$99.20M
-$99.20M
Dec 2000
-$761.10M(-113.3%)
-
-
Dec 1999
-$356.80M(-227.9%)
-
-
Dec 1998
-$108.80M
-
-

FAQ

  • What is Elevance Health, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. annual cash from investing year-on-year change?
  • What is Elevance Health, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. quarterly cash from investing year-on-year change?
  • What is Elevance Health, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. TTM cash from investing year-on-year change?

What is Elevance Health, Inc. annual cash from investing?

The current annual cash from investing of ELV is -$5.17B

What is the all-time high annual cash from investing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high annual cash from investing is $3.00B

What is Elevance Health, Inc. annual cash from investing year-on-year change?

Over the past year, ELV annual cash from investing has changed by +$405.00M (+7.27%)

What is Elevance Health, Inc. quarterly cash from investing?

The current quarterly cash from investing of ELV is -$1.22B

What is the all-time high quarterly cash from investing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high quarterly cash from investing is $4.16B

What is Elevance Health, Inc. quarterly cash from investing year-on-year change?

Over the past year, ELV quarterly cash from investing has changed by -$823.00M (-205.24%)

What is Elevance Health, Inc. TTM cash from investing?

The current TTM cash from investing of ELV is -$3.45B

What is the all-time high TTM cash from investing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high TTM cash from investing is $3.99B

What is Elevance Health, Inc. TTM cash from investing year-on-year change?

Over the past year, ELV TTM cash from investing has changed by +$1.11B (+24.40%)
On this page